ECTRIMS

🎥 🍿 Direct from the auditorium of this year's Opening Session, ECTRIMS is proud to share our 40th anniversary film: "What is ECTRIMS?" This short film traces the rich history of ECTRIMS. It starts with the vision of one of our pioneering founders, Professor Otto R. Hommes. And it ends with a tribute to our collective achievements, the incredible progress we’ve made since our humble beginnings, and the community we’ve built over the last four decades. Thank you for being part of this incredible journey #ECTRIMS2024 PLAY HERE 👉 https://bit.ly/3MWzrJQ ___________ Featuring: Bernard Uitdehaag Amsterdam UMC | Frederik Barkhof VU University Medical Center - Amsterdam Neuroscience | Maria Pia Amato Università degli Studi di Firenze | Xavier Montalban CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) | Alan J Thompson UCL | Ludwig Kappos University Hospital Basel | maria trojano Università degli Studi di Bari | Mar Tintore Subirana CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) | Powered by Congrex Switzerland

👩What are the unmet needs of women with MS? 🗓️ Join our upcoming webinar on 5 November at 18:30-19:30 CET as our panel of experts discusses the results of a groundbreaking global initiative to deepen our understanding of the knowledge gaps and prioritisation of issues affecting women living with MS. 🌍 The initiative was supported by the International Advisory Committee on Clinical Trials in MS – a global group of leaders in clinical trials and research sponsored by ECTRIMS and the National MS Society. Don't miss the chance to hear from Prof. Mar Tintore Subirana of CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Prof. Ruth Anne Marrie of Dalhousie University & Dr. Lindsay Ross of Cleveland Clinic - who will share key takeaways from the scoping review as well as discuss the continued gaps in knowledge, considerations around clinical management of women living with MS, and strategy. Moderated by Rachel Horne, journalist and founder of the Rachel Horne Prize. The webinar is only a week away (5 November) - register now! ➡️ https://bit.ly/48HlVUR #MS #webinar #Women'sHealth

Even though #ECTRIMS2024 has ended, your learning journey doesn't have to. We are thrilled to offer continued access to our specialised Educational Sessions. Dive into a range of topics including: 🔹 Challenges in Treating MS 🔹 Rehabilitation Throughout the Disease Course 🔹 Immunological Changes and DMT in MS 🔹 Brain Interfaces in Demyelinating Disorders 🔗 Access these valuable resources today by logging into your registration account, selecting your desired sessions, and completing your registration. Enhance your practice and deepen your understanding in the field! Login 👉 👉 👉 https://bit.ly/3AVrdPK

It's been a month since #ECTRIMS2024 concluded, yet the sharing of insights persists. Be sure to check out the ECTRIMS 2024 Highlight Slide Deck on our website. This deck includes a curated selection of the best abstracts from the event, sorted by topic for easy reference. We invite you to download and distribute this essential resource among your colleagues and peers ➡️ https://bit.ly/3TqUzM2 #MS #MultipleSclerosis #MSResearch

📢 New Podcast Alert! 🔬 What does the next 20 years hold for MS therapies? 🎯 What novel targets are being investigated? 💊 What clinical trials are in the pipeline and when can we expect new medications in the market? "Another aspect I think in the therapeutic arena that may be interesting is other methods of immune intervention and bringing the B cell depletion into the CNS," says Prof. Ludwig Kappos of Universitätsspital Basel (USB). Tune in to our latest podcast as host Brett Drummond of MStranslate explores these questions and more with Prof. Kappos and Prof. Heinz Wiendl of University of Freiburg. Listen now! Web: https://bit.ly/4e0LPUz Apple: https://apple.co/4e57cUp Spotify: https://spoti.fi/3YATSmo Don't miss our future episodes! Subscribe via Apple Podcasts or Spotify. #MS #MSResearch #MSTherapy

🎓🌍 The ECTRIMS Fellowships offer a valuable opportunity to enhance your expertise and advance your career in #MS research and care. 💡 Discover the benefits and apply by 1 December 2024 to join a network of leading MS professionals. Find out more here: https://lnkd.in/exYYXvdg #ECTRIMSFellowships #ClinicalTraining #MSResearch #CareerDevelopment

Heading to Barcelona for #ECTRIMS2025 Next Year? Your ultimate congress guide is just a click away! Bookmark our detailed A to Z page on the official congress website, your essential resource for everything ECTRIMS. It's packed with all the latest updates and vital congress information you need. Stay ahead and keep informed! Check it regularly: https://bit.ly/3Yvxw5Q #CongressPrep #StayUpdated

👉 Apply Now for the 2025 ECTRIMS Fellowship Programmes! Are you ready to unlock your potential and advance your career in research and care? Explore the ECTRIMS fellowship programmes tailored for clinical practitioners, researchers, nurses, and AHP professionals. _____________________________ 🔵 CLINICAL TRAINING: Acquire specialised skills, collaborate with academia & industry leaders, and propel your clinical career to new heights 🔬 RESEARCH FELLOWSHIP: Lead groundbreaking research, contribute to medical advancements, and become a thought leader in your domain 💉 NURSES & AHP PROFESSIONAL TRAINING: Elevate your expertise, enhance patient care, and open doors to diverse career opportunities 🌫️ MAGNIMS-ECTRIMS FELLOWSHIP: Utilize cutting-edge magnetic resonance techniques to advance your expertise in multiple sclerosis studies 🧠 (NEW!) MEDEN-ECTRIMS FELLOWSHIP: Gain invaluable clinical experience in neuromyelitis optica spectrum and myelin oligodendrocyte glycoprotein antibody-associated disorders. _____________________________ Discover how the ECTRIMS fellowships can accelerate your career, and send your application in today ➡️ https://lnkd.in/exYYXvdg ⏳ Deadline: 1 December 2024 🔄 P.S. If you know someone in your circle who might be interested, please share this post! #ms #msresearch #fellowships #nurses #AHP #NMOSD #MOGAD

🦾 How is artificial intelligence (AI) shaping the future of multiple sclerosis (MS) research and clinical care? And what are its risks and limitations? 🩺 In our latest MS Research Spotlight, Professor Douglas Arnold from McGill University says: “Today, the focus is on the application of AI in prognosis, particularly in predicting disability progression and disease activity.” 💊“We would like to develop a tool that can predict future individual treatment response and outcomes under different treatments. We are working on a deep learning model that can predict new and enlarging lesions counts in follow-up MRIs under different treatments," adds Professor Tal Arbel from McGill University. 🚧 However, many challenges remain in advancing AI's role in MS research and clinical care. 🔎Explore the key issues and opportunities in our latest Research Spotlight. https://bit.ly/3A16VUF #MS #MSResearch #MultipleSclerosis #AI #MachineLearning #Healthcare #MedicalResearch #ClinicalCare #Innovation #DeepLearning

📣 News from the MS Journal, the official journal of ECTRIMS! 🎉Join us in congratulating ECTRIMS Executive Committee member and CEMCAT (Centre d'Esclerosi Múltiple de Catalunya) Deputy Director Jaume Sastre-Garriga on his appointment as the new Editor in Chief (EIC), effective January 1, 2025. A heartfelt thank you to current EIC Alan J Thompson of UCL for his 18 years of leadership and dedication that shaped the MS Journal’s success. Alan will remain a member of the MS Journal Editorial Board. For more about this news and the MS Journal visit https://bit.ly/3Y8foNT